Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites-Reference-Cited by-同舟云学术

Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites

Published:2016-08-24 Issue:4 Volume:64 Page:1265-1272
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Dam Gitte¹,Vilstrup Hendrik¹,Watson Hugh²,Jepsen Peter¹³

Affiliation:

1. Department of Hepatology and Gastroenterology; Aarhus University Hospital; Aarhus Denmark

2. Sanofi Aventis R&D; Paris France

3. Department of Clinical Epidemiology; Aarhus University Hospital; Aarhus Denmark

Funder

Danish Council for Independent Research under the Danish Agency for Science, Technology and Innovation

Publisher

Wiley

Subject

Hepatology

Reference26 articles.

1. Use and overuse of proton pump inhibitors in cirrhotic patients;Chavez-Tapia;Med Sci Monit,2008

2. Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis;Dultz;Aliment Pharmacol Ther,2015

3. Association of proton pump inhibitor therapy with hepatic encephalopathy in hepatitis B virus-related acute-on-chronic liver failure;Zhao-Ni;Hepat Mon,2014

4. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis;Janarthanan;Am J Gastroenterol,2012

5. The bacterial content of the small intestine in normal and cirrhotic subjects: relation to methionine toxicity;Martini;Clin Sci,1957

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks;Current Gastroenterology Reports;2024-08-21

2. Blutungen bei Lebererkrankungen;Medizinische Klinik - Intensivmedizin und Notfallmedizin;2024-08-13

3. Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study;JHEP Reports;2024-08

4. Letter: Risks of proton pump inhibitor treatment in cirrhotic patients—Authors' reply;Alimentary Pharmacology & Therapeutics;2024-07-12

5. A Comprehensive Review on Hepatic Encephalopathy: Pathophysiology, Symptoms, Epidemiology, Classification, Diagnosis and Treatment;Journal for Research in Applied Sciences and Biotechnology;2024-07-08